Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow failure.

Grover C Bagby, Jeffrey M Lipton, Elaine M Sloand

    Hematology. American Society of Hematology. Education Program
    |November 25, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium.

    Journal of pediatric hematology/oncology·2026
    Same author

    RPS19 and RPL5 haploinsufficient models reveal divergent ribosomal subunit controls of fetal hematopoiesis.

    Nature communications·2026
    Same author

    The ASPHO 2025 Distinguished Career Award to Dr Peter E. Newburger.

    Pediatric blood & cancer·2026
    Same author

    2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

    Leukemia·2025
    Same author

    Placental growth factor enhances inflammatory toll-like receptor responses in syncytiotrophoblasts.

    Placenta·2025
    Same author

    Acute myeloid leukemia management and research in 2025.

    CA: a cancer journal for clinicians·2024

    Recent advances in cell biology and genetics illuminate bone marrow failure syndromes, aiding differential diagnosis and therapy development. Understanding molecular mechanisms is key for effective treatment strategies in pancytopenia and hypoplastic bone marrow cases.

    Area of Science:

    • Cell Biology
    • Molecular Biology
    • Genetics

    Background:

    • Bone marrow failure syndromes (BMFS) present significant diagnostic and therapeutic challenges due to clinical overlap.
    • Advances in understanding pathophysiological mechanisms are crucial for developing targeted therapies.

    Purpose of the Study:

    • To review current diagnostic and management approaches for inherited and acquired bone marrow failure syndromes.
    • To highlight the role of molecular and cellular pathogenetic mechanisms in guiding therapeutic decisions.
    • To discuss emerging therapies for hypoplastic myelodysplastic syndromes (MDS).

    Main Methods:

    • Review of inherited BMFS including Fanconi anemia, dyskeratosis congenita, Diamond-Blackfan anemia, and Shwachman-Diamond syndrome.
    • Evidence-based approach to acquired hypoplastic states, emphasizing T-lymphocyte mediated marrow failure.

    Related Experiment Videos

  • Analysis of therapeutic options for hypoplastic MDS, including novel agents and stem cell transplantation.

    • Main Results:

    • Progress in identifying causative genes for inherited BMFS, though protein function remains complex.
    • Immunosuppressive therapy and stem cell transplantation are key for T-lymphocyte mediated marrow failure.
    • Promising activity observed with DNA demethylating agents, thalidomide, arsenic trioxide, and immunosuppressive therapy for hypoplastic MDS.

    Conclusions:

    • Defining molecular mechanisms is essential for rational therapeutic approaches in BMFS.
    • Diagnosis of dyskeratosis congenita and Fanconi anemia should be considered in both children and adults.
    • Allogeneic bone marrow transplantation offers curative potential for hypoplastic MDS.